Aurobindo Pharma to acquire seven oncology products from US-based Spectrum Pharmaceuticals in a USD 300 mn deal: Regulatory filing.

Aurobindo Pharma to acquire seven oncology products from US-based Spectrum Pharmaceuticals in a USD 300 mn deal: Regulatory filing.

Aurobindo Pharma to acquire seven oncology products from US-based Spectrum Pharmaceuticals in a USD 300 mn deal: Regulatory filing.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.